Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must undergo primary unilateral first metatarsal bunionectomy~* Pain intensity must be moderate to severe following removal of a continuous popliteal sciatic block~* Female patients must be postmenopausal, surgically sterile, or practicing an effective method of birth control if they are sexually active.~Exclusion Criteria:~* Patients will be excluded from the study if they have a history of seizure disorder or epilepsy~* History of malignancy within the past 2 years before starting the study~* History of alcohol or drug abuse~* Evidence of active infections that may spread to other areas of the body~* Clinical laboratory values reflecting severe renal insufficiency~* Moderately or severely impaired hepatic function~* Currently treated with anticonvulsants, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), neuroleptics, or serotonin norepinephrine reuptake inhibitor (SNRI).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 004 (Type: PLACEBO_COMPARATOR): placebo 1 capsule q4-6 hrs for 3 days
- 003 (Type: ACTIVE_COMPARATOR): oxycodone 10mg capsule q4-6 hrs for 3 days
- 001 (Type: EXPERIMENTAL): Tapentadol (CG5503) 50mg capsule q4-6 hrs for 3 days
- 002 (Type: EXPERIMENTAL): Tapentadol (CG5503) 75mg capsule q4-6 hrs for 3 days

Based on this trial design, predict the completion outcome and termination type (if applicable).